Results from a new clinical trial suggest that a high-fiber plant-based diet could benefit patients at risk for developing ...

Results from a new clinical trial suggest that a high-fiber plant-based diet could benefit patients at risk of developing ...

A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data presented at the annual meeting of the American Society of Clinical ...

A potential cure for a rare type of blood cancer is currently being used to treat 150 patients at various healthcare centers ...

A new four-drug combination is highly effective and safe in patients with newly diagnosed multiple myeloma, according to data ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today two-year follow-up data from the Phase ...

An oral presentation at ASCO & EHA Congress from the CARTITUDE-1 study highlighting heavily pre-treated patients that remain alive and progression-free for more than 5 years after a single CARVYKTI® ...

As the authors reported in Radiology Case Reports, the patient had no history of cancer and had no pain, weakness, numbness, or other spine-related symptoms. Lab tests confirmed she had severe anemia; ...

Pfizer-backed CellCentric has secured $120 million in series C funds as the British biotech prepares to take its multiple myeloma drug into pivotal trials. The candidate in question, an oral p300 ...

(RTTNews) - British drug maker GSK plc (GSK.L, GSK) announced Monday the approval of Blenrep combinations by Japan's Ministry of Health, Labour and Welfare or MHLW for the treatment of adults with ...

We know that prostate cancer, breast cancer and colon cancer disproportionately affect African Americans, but there is a lesser discussed cancer that also affects us more: multiple myeloma (MM).

“There is no cure for multiple myeloma. We believe there remains an unmet medical need for CAR-T therapies that are efficacious, safe, and accessible. Anito-cel has the unique potential to ...